Pharmafile Logo

The Social Dilemma

- PMLiVE

In the June issue of PME, Dennis O’Brien, Lucid CEO, explores the relationship between social media and pharma.

“There is a party going on next door, but our industry is too scared to go in,” comments Dennis.

The way the world communicates has changed radically over the last 15 years, but pharma simply isn’t configured to take advantage of this shifting landscape. Other industries are building infrastructure to leverage this enormous channel, but pharma is still reliant on the traditional communication routes, held back by the fear of regulations and the level of investment it will take.

Dennis concludes, “We’re scared to go to the party. We must move from being scared to being real.”

Read more about what Dennis and other industry thought leaders have to say on the role of social media in pharma here.

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid team : because you’re worth it!

Lucid group reward the team for an amazing year

Lucid celebrate big wins at PMEA 2015

Success for Lucid at PMEA 2015

Lucid invests in their Futures programme with a new hire

Lucid Group continues their expansion

Janus kinase inhibitors are amongst the most read abstracts at the American College of Rheumatology 2015

Rheumatologists eagerly await trial data for Janus kinase inhibitors

Making a difference to patients with IBD

Changing lives with medical education

Lucid Group showcases new KOL identification and mapping tool

Advancing Expert identification with digital new tool from Lucid Group

Lucid CEO discusses his inspiration and passion for changing patients’ lives

Changing patients' lives with innovative methodologies in medical education